Shu Chin Ma, MS, MPhil, PhD, EMBA

Shu Chin Ma, M.S., MPhil, Ph.D., EMBA, serves as C-Path Vice President, Model-Informed Drug Development and Quantitative Medicine. Shu Chin comes from a varied background of academia, regulatory, consultancy and the pharmaceutical industry. In her previous industry roles, she served as the head of clinical pharmacology and pharmacometrics, leading teams of scientists in therapeutic areas including rare, neurodegenerative and metabolic diseases, and blood and solid oncology from FIH dose selection to NDA filings. Shu Chin was a part of the Certara Strategic Consultancy where she worked with various client companies on gap analysis, trial design, pharmacometrics analyses and regulatory filings. She was an ORISE fellow at Division of Pharmacometrics at the U.S. Food and Drug Administration and worked as a primary reviewer at the office of generic drugs prior to joining Certara. Shu Chin received a Master of Science degree from the Department of Chemical and Biomolecular Engineering at Cornell University, a Master of Philosophy from the department of Electrical Engineering at Yale University and a Ph.D. in Biomedical Engineering also from Yale. Dr. Ma is passionate about novel solutions to expedite safe drug development process.